Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

被引：0
|
作者：
E. L. L. M. De Schryver
J. van Gijn
L. J. Kappelle
P. J. Koudstaal
A. Algra
机构：
[1] University Medical Centre,Dept. of Neurology
[2] University Medical Centre Utrecht H.02.128,Dept. of Neurology
[3] Erasmus Medical Centre,Julius Centre for Health Sciences and Primary Care
[4] University Medical Centre,undefined
来源：
Journal of Neurology | 2005年 / 252卷
关键词：
adherence; stroke; prevention; secondary; compliance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1316 / 1321
页数：5
相关论文
共 50 条
  • [21] Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
    Sacquegna, Tommaso
    Zaniboni, Anna
    Rubboli, Andrea
    Procaccianti, Gaetano
    Crisci, Michela
    Maioli, Fabiola
    Arnone, Giorgia
    Di Pasquale, Giuseppe
    ITALIAN JOURNAL OF MEDICINE, 2015, 9 (04) : 314 - 322
  • [22] The efficacy of novel oral anticoagulants for the secondary stroke prevention in the real world
    Nakase, T.
    Sasaki, M.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 275 - 275
  • [23] Monitoring of direct oral anticoagulants plasma levels for secondary stroke prevention
    Siedler, Gabriela
    Macha, Kosmas
    Stoll, Svenja
    Plechschmidt, Johannes
    Wang, Ruihao
    Gerner, Stefan T.
    Strasser, Erwin
    Schwab, Stefan
    Kallmuenzer, Bernd
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (05) : 1138 - 1145
  • [24] Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention
    Frol, Senta
    Sernec, Lana Podnar
    Hudnik, Liam Korosec
    Sabovic, Miso
    Oblak, Janja Pretnar
    CLINICAL DRUG INVESTIGATION, 2020, 40 (11) : 1053 - 1061
  • [25] The new anticoagulants - their role in secondary prevention of thromboembolism after stroke
    Seiffge, David J.
    Nedeltchev, Krassen
    Lyrer, Philippe A.
    THERAPEUTISCHE UMSCHAU, 2012, 69 (09) : 517 - 522
  • [26] Guideline Adherence: Are Patients with Atrial Fibrillation Receiving Oral Anticoagulants for Stroke Prevention?
    Po, Helen L.
    Yu, Hui Fen
    Lin, Hsiao Chu
    Lin, Ya Ju
    Chen, Yi Min
    Chou, Chao Liang
    Chen, Lu An
    Huang, Ying Ting
    CEREBROVASCULAR DISEASES, 2014, 38 : 96 - 96
  • [27] PIOGLITAZONE MODELLING AS A SECONDARY PREVENTION STRATEGY AFTER ISCHAEMIC STROKE
    Wallis, S.
    Smith, C.
    Cameron, A.
    Dawson, J.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 129 - 129
  • [28] Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke
    Ringleb, PA
    Schwark, C
    Schwaninger, M
    Schellinger, PD
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 359 - 367
  • [29] Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer
    Atterman, A.
    Asplund, K.
    Friberg, L.
    Engdahl, J.
    JOURNAL OF INTERNAL MEDICINE, 2020, 288 (04) : 457 - 468
  • [30] Outcome of Secondary Stroke Prevention in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants
    Nakase, Taizen
    Moroi, Junta
    Ishikawa, Tatsuya
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (05): : 1174 - 1177
12345